| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/1994 | CA2088293A1 Cell line and assay to determine biological activity of retinoids |
| 07/27/1994 | EP0608121A1 Fibrinogen processing apparatus, method and container |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607925A2 Transgenic mammals as models for thrombocytopenia and/or megakaryocyte leukemia |
| 07/27/1994 | EP0607593A2 Process for obtaining cell cultures with a higher content of autologous cytonines |
| 07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
| 07/27/1994 | EP0607408A1 Transvascular and intracellular delivery of lipidized proteins |
| 07/27/1994 | EP0607392A1 Plasma fraction purification |
| 07/27/1994 | EP0607368A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607325A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27 AND USE IN OSTEOPOROSIS TREATMENT |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
| 07/27/1994 | EP0607234A1 Method of extracting proteins utilizable in foodstuffs from a protein-containing substance. |
| 07/27/1994 | EP0607222A1 Dendrimeric polychelants |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0576589A4 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | EP0464140B1 Hydrophobic attachment site for adhesion peptides |
| 07/27/1994 | EP0461155B1 Improved methods for in vitro dna amplification and genomic cloning and mapping |
| 07/27/1994 | EP0399001B1 T-cell epitope as carriers molecule for conjugate vaccines |
| 07/27/1994 | EP0346500B1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/27/1994 | CN1089951A Novel glycoforms of soluble complement receptor 1 |
| 07/27/1994 | CN1089950A Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| 07/27/1994 | CA2113868A1 Ultra-pure human interleukin-6 |
| 07/26/1994 | US5332808 DNA encoding a ribosome inactivating protein |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | US5332803 Solvent extraction from wheat, complexing with polysaccharide |
| 07/26/1994 | US5332802 Human collagen processing and autoimplant use |
| 07/26/1994 | US5332726 Antithrombotic peptides and pseudopeptides |
| 07/26/1994 | US5332678 Cleaving s-s bond with lipoic acid, vitamin B12, testosterone, thyroid hormones |
| 07/26/1994 | US5332672 Prevention of ES cell differentiation by ciliary neurotrophic factor |
| 07/26/1994 | US5332671 Production of vascular endothelial cell growth factor and DNA encoding same |
| 07/26/1994 | US5332669 Prostate-derived mitogen |
| 07/26/1994 | US5332664 Human calcitonin precursor polyprotein structural gene |
| 07/26/1994 | US5332658 Recombinant human rotavirus VP7 serotype 4 |
| 07/26/1994 | US5332583 Genetic engineering |
| 07/26/1994 | US5332475 Cross-linking collagenous product |
| 07/26/1994 | CA2113981A1 Codon optimized dna sequence for insect toxin aait |
| 07/26/1994 | CA2113979A1 Heterologous signal sequences for secretion of insect controlling proteins |
| 07/26/1994 | CA2087739A1 Putative target for an immunotherapeutic approach to prevent, and stop the neurological and other symptoms of lesch-nyhan syndrome in humans: reconstructed cdna and protein antisense to the human hprt gene |
| 07/26/1994 | CA2087738A1 Potential target for an immunotherapeutic approach to stop huntington's chorea in humans: cdna and protein structures for an intracellular activator of the human glutamate receptor, brain lactate dehydrogenase and vacuolar atpase reconstructed from the antisense strand of baboon urate oxi dase gene |
| 07/26/1994 | CA2087737A1 Potential target for immunotherapy to prevent and cure rheumatoid arthritis and asthma in humans: cdna and protein structures for an intracellular activator of phospholipase a2 reconstructed from the antisense strand of human app gene |
| 07/26/1994 | CA1330961C Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
| 07/26/1994 | CA1330943C Growth inhibiting agent and the use thereof |
| 07/26/1994 | CA1330941C Sustained release composition from salt-form reactants and method for making |
| 07/24/1994 | WO1994017098A1 Synthetic peptides and vaccines against parvovirus |
| 07/21/1994 | WO1994016331A1 Diagnosis of leishmaniasis |
| 07/21/1994 | WO1994016328A1 Synthetic oligopeptides analogous to protein signal sequences methods of identification and methods of use |
| 07/21/1994 | WO1994016109A1 Membrane fusion events and means for altering same |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994016089A1 Viral amplification of recombinant messenger rna in transgenic plants |
| 07/21/1994 | WO1994016088A1 Anti-nutritional protein |
| 07/21/1994 | WO1994016087A1 Plant virus-resistant transgenic plants and method for producing same |
| 07/21/1994 | WO1994016085A2 Hybrid proteins having cross-linking and tissue-binding activities |
| 07/21/1994 | WO1994016084A1 Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens |
| 07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/21/1994 | WO1994016080A1 An in vitro/in vivo method for identifying anti-neoplastic drugs |
| 07/21/1994 | WO1994016079A2 Novel bacillus thuringiensis toxins active against corn rootworm larvae |
| 07/21/1994 | WO1994016078A2 High lysine derivatives of alpha-hordothionin |
| 07/21/1994 | WO1994016077A1 Method for breeding disease resistance into plants |
| 07/21/1994 | WO1994016076A1 Antimicrobial-protein-producing endosymbiotic microorganisms |
| 07/21/1994 | WO1994016075A2 Process for producing m-csf 223 |
| 07/21/1994 | WO1994016074A2 High molecular weight b-cell growth factor: interleukin-14 |
| 07/21/1994 | WO1994016073A2 Methods and reagents for inhibiting furin endoprotease |
| 07/21/1994 | WO1994016072A1 Vectors useful for controlling hiv-1 replication and methods for using the same |
| 07/21/1994 | WO1994016071A2 Assays and genes for cell death |
| 07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
| 07/21/1994 | WO1994016069A2 Ras associated gap proteins |
| 07/21/1994 | WO1994016068A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | WO1994016067A1 Serotoninergic receptors (5ht6 and 5ht7) and use thereof |
| 07/21/1994 | WO1994016066A1 Agents for the prevention and treatment of hiv replication and aids in humans |
| 07/21/1994 | WO1994016065A1 Producing cells for transplantation to reduce host rejection and resulting cells |
| 07/21/1994 | WO1994016062A1 Complement regulatory proteins of herpesvirus saimiri |
| 07/21/1994 | WO1994016060A1 Mutants of hiv for supression of hiv infection |
| 07/21/1994 | WO1994015968A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015964A1 NF-ATp, A T LYMPHOCYTE DNA-BINDING PROTEIN |
| 07/21/1994 | WO1994015963A1 Novel cell cortex protein |
| 07/21/1994 | WO1994015962A2 Derivatized calcitonins |
| 07/21/1994 | WO1994015961A2 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | WO1994015960A1 Peptide with glutamate liberation inhibitor and calcium channel inhibitor activities |
| 07/21/1994 | WO1994015958A2 Peptide inhibitors of cell adhesion |
| 07/21/1994 | WO1994015953A1 Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases |
| 07/21/1994 | WO1994015952A1 Method for production of a kappa-casein glycomacropeptide and use of a kappa-casein glycomacropeptide |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015942A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015634A1 Tat and rev oligopeptides in hiv treatment |
| 07/21/1994 | WO1994015630A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/21/1994 | WO1994015628A1 Electrically conducting synthetic peptide complexes |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015618A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994015587A2 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |